
Bong-sook Baek
Examiner (ID: 13827, Phone: (571)270-5863 , Office: P/1621 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1621, 1614, 4161, 1629, 1611 |
| Total Applications | 1174 |
| Issued Applications | 496 |
| Pending Applications | 83 |
| Abandoned Applications | 612 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20264103
[patent_doc_number] => 12435078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => Pyridazinones and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/648606
[patent_app_country] => US
[patent_app_date] => 2018-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 86
[patent_figures_cnt] => 86
[patent_no_of_words] => 106906
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16648606
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/648606 | Pyridazinones and methods of use thereof | Sep 17, 2018 | Issued |
Array
(
[id] => 15663921
[patent_doc_number] => 10596167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan
[patent_app_type] => utility
[patent_app_number] => 16/133553
[patent_app_country] => US
[patent_app_date] => 2018-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 44908
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16133553
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/133553 | Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan | Sep 16, 2018 | Issued |
Array
(
[id] => 14069077
[patent_doc_number] => 20190083426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => COMPOSITIONS AND METHODS FOR INCREASING THE METABOLIC LIFETIME OF DEXTROMETHORPHAN AND RELATED PHARMACODYNAMIC EFFECTS
[patent_app_type] => utility
[patent_app_number] => 16/129531
[patent_app_country] => US
[patent_app_date] => 2018-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16129531
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/129531 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Sep 11, 2018 | Issued |
Array
(
[id] => 13790663
[patent_doc_number] => 20190008870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => COMPOSITIONS AND METHODS FOR LIPID METABOLISM DISORDER
[patent_app_type] => utility
[patent_app_number] => 16/127498
[patent_app_country] => US
[patent_app_date] => 2018-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16127498
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/127498 | COMPOSITIONS AND METHODS FOR LIPID METABOLISM DISORDER | Sep 10, 2018 | Abandoned |
Array
(
[id] => 13790525
[patent_doc_number] => 20190008801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => COMPOSITIONS AND METHODS FOR INCREASING THE METABOLIC LIFETIME OF DEXTROMETHORPHAN AND RELATED PHARMACODYNAMIC EFFECTS
[patent_app_type] => utility
[patent_app_number] => 16/127832
[patent_app_country] => US
[patent_app_date] => 2018-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44515
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16127832
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/127832 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Sep 10, 2018 | Issued |
Array
(
[id] => 15615953
[patent_doc_number] => 20200078381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-12
[patent_title] => LIPOSOMAL ENCAPSULATION METHOD AND DEVICES
[patent_app_type] => utility
[patent_app_number] => 16/126781
[patent_app_country] => US
[patent_app_date] => 2018-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16126781
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/126781 | LIPOSOMAL ENCAPSULATION METHOD AND DEVICES | Sep 9, 2018 | Abandoned |
Array
(
[id] => 13790523
[patent_doc_number] => 20190008800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => COMPOSITIONS AND METHODS FOR INCREASING THE METABOLIC LIFETIME OF DEXTROMETHORPHAN AND RELATED PHARMACODYNAMIC EFFECTS
[patent_app_type] => utility
[patent_app_number] => 16/119852
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16119852
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/119852 | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | Aug 30, 2018 | Issued |
Array
(
[id] => 14273511
[patent_doc_number] => 20190134040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => HETEROCYCLYLAMINES AS PI3K INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/112160
[patent_app_country] => US
[patent_app_date] => 2018-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16112160
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/112160 | Heterocyclylamines as PI3K inhibitors | Aug 23, 2018 | Issued |
Array
(
[id] => 15551723
[patent_doc_number] => 20200060273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => FUNGICIDAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/110144
[patent_app_country] => US
[patent_app_date] => 2018-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8592
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16110144
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/110144 | FUNGICIDAL COMPOSITIONS | Aug 22, 2018 | Abandoned |
Array
(
[id] => 13618511
[patent_doc_number] => 20180360807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => METHODS FOR THE TREATMENT OF DISEASES AMELIORATED BY PDE4 INHIBITION USING DOSAGE TITRATION OF APREMILAST
[patent_app_type] => utility
[patent_app_number] => 16/109634
[patent_app_country] => US
[patent_app_date] => 2018-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16109634
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/109634 | METHODS FOR THE TREATMENT OF DISEASES AMELIORATED BY PDE4 INHIBITION USING DOSAGE TITRATION OF APREMILAST | Aug 21, 2018 | Abandoned |
Array
(
[id] => 16381900
[patent_doc_number] => 10806710
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Bupropion as a modulator of drug activity
[patent_app_type] => utility
[patent_app_number] => 16/107472
[patent_app_country] => US
[patent_app_date] => 2018-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 44460
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16107472
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/107472 | Bupropion as a modulator of drug activity | Aug 20, 2018 | Issued |
Array
(
[id] => 13924981
[patent_doc_number] => 20190046006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => DRY SANITIZATION APPARATUS COMPRISING COPPER
[patent_app_type] => utility
[patent_app_number] => 16/100061
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3641
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16100061
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/100061 | DRY SANITIZATION APPARATUS COMPRISING COPPER | Aug 8, 2018 | Abandoned |
Array
(
[id] => 13586339
[patent_doc_number] => 20180344718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => METHOD OF TREATING HYPERTENSION
[patent_app_type] => utility
[patent_app_number] => 16/044682
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6726
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16044682
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/044682 | METHOD OF TREATING HYPERTENSION | Jul 24, 2018 | Abandoned |
Array
(
[id] => 14306237
[patent_doc_number] => 20190142822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => Treatment of Breast Cancer with Liposomal Irinotecan
[patent_app_type] => utility
[patent_app_number] => 16/036885
[patent_app_country] => US
[patent_app_date] => 2018-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16036885
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/036885 | Treatment of Breast Cancer with Liposomal Irinotecan | Jul 15, 2018 | Abandoned |
Array
(
[id] => 14156469
[patent_doc_number] => 20190105337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => METHODS OF TREATING BACTERIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/029388
[patent_app_country] => US
[patent_app_date] => 2018-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16029388
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/029388 | METHODS OF TREATING BACTERIAL INFECTIONS | Jul 5, 2018 | Abandoned |
Array
(
[id] => 19563588
[patent_doc_number] => 12138339
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => Dye composition based on copolymers derived from the polymerization of at least one crotonic acid monomer or crotonic acid derivative and on silicone
[patent_app_type] => utility
[patent_app_number] => 16/623131
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11035
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 290
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16623131
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/623131 | Dye composition based on copolymers derived from the polymerization of at least one crotonic acid monomer or crotonic acid derivative and on silicone | Jun 21, 2018 | Issued |
Array
(
[id] => 13574819
[patent_doc_number] => 20180338958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => METHOD OF TREATMENT USING INHIBITORS OF MITOSIS
[patent_app_type] => utility
[patent_app_number] => 16/000756
[patent_app_country] => US
[patent_app_date] => 2018-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11545
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16000756
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/000756 | METHOD OF TREATMENT USING INHIBITORS OF MITOSIS | Jun 4, 2018 | Abandoned |
Array
(
[id] => 15175213
[patent_doc_number] => 20190358198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => USE OF OVATODIOLIDE FOR PREPARING A COMPOSITION FOR INHIBITING PROTEIN SYNTHESIS OF GASTRIC HELICOBACTER PYPORI
[patent_app_type] => utility
[patent_app_number] => 15/987438
[patent_app_country] => US
[patent_app_date] => 2018-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2186
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15987438
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/987438 | USE OF OVATODIOLIDE FOR PREPARING A COMPOSITION FOR INHIBITING PROTEIN SYNTHESIS OF GASTRIC HELICOBACTER PYPORI | May 22, 2018 | Abandoned |
Array
(
[id] => 13427977
[patent_doc_number] => 20180265531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => TC-PTP INHIBITORS AS APC ACTIVATORS FOR IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 15/986313
[patent_app_country] => US
[patent_app_date] => 2018-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19922
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15986313
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/986313 | TC-PTP inhibitors as APC activators for immunotherapy | May 21, 2018 | Issued |
Array
(
[id] => 14068959
[patent_doc_number] => 20190083367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => Coated Particles and Their Uses
[patent_app_type] => utility
[patent_app_number] => 15/981601
[patent_app_country] => US
[patent_app_date] => 2018-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15981601
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/981601 | Coated particles and their uses | May 15, 2018 | Issued |